Screenshots

Description

According to current protocols, sentinel lymph node biopsy remains the gold standard, and in this perspective, a preoperative statistical tool can be useful to communicate to the patient the probability that it will be positive. The future goal of the application of the models presented is to avoid sentinel lymph node biopsy in low-risk patients and avoid completion axillary lymph node dissection in patients with positive sentinel lymph node
Risk of Lymph Node Metastasis Tool
In the univariate analysis, all the risk factors considered (Age, Grading, Tumor Size, LVI, Multifocality, Molecular Subtype) are significantly associated with the occurrence of metastatic lymph nodes. In the multivariate analysis, all the significant variables in the univariate were included. A nomogram was developed with the predictors of the multivariate model to calculate a score for the probability of metastatic sentinel lymph nodes.
Risk of >3 Lymph Node Metastasis Tool
In addition to assessing the risk of occurrence of metastatic lymph nodes, an in-depth study was carried out to evaluate the risk of having more than 3 metastatic lymph nodes (equivalent to the pN2a stage), due to the therapeutic implication in this finding. In patients with more than 3 metastatic lymph nodes, in fact, the Radiotherapy of the axillary and supraclavicular lymph node stations is indicated.
Risk of Non-Sentinel Node Metastasis
Discordance of intraoperative analysis with definitive histology of the sentinel lymph node in breast cancer leads to completion axillary lymph node dissection, which only in 35-50% shows additional nodal metastases. A nomogram was developed to calculate a score for the probability of Non-sentinel lymph node metastases in breast cancer patients with a positive sentinel lymph node.

WARNING:
All tools must not be considered as an alternative but as a complement tool to the experience and ability of the surgeon in the decisional process of treating breast cancer patients.

What’s New

Version 1.2

Two more tools have been added one to predict Lymph node metastasis based on tumour characteristics and one to predict the probability of having more than 3 Lymph Node Metastasis.
New name of the App Breast CA LN Status
Interface update.
Graphics update.
Icon update.

Ratings and Reviews

5.0 out of 5
4 Ratings

4 Ratings

-fdd ,

Utile e intuitiva

Bravissimi, app molto utile e facile da usare

iCiomps ,

Useful application!

Nice opportunity to calculate bed-side the risk for the patients!!! Very good Italian job!!!

App Privacy

The developer, diepflap.it Medical Software, has not provided details about its privacy practices and handling of data to Apple. For more information, see the developer’s privacy policy.

No Details Provided

The developer will be required to provide privacy details when they submit their next app update.

Supports

  • Family Sharing

    Up to six family members will be able to use this app with Family Sharing enabled.

More By This Developer

You May Also Like